Study to Evaluate Safety & Effectiveness of Spinal Sealant
- Conditions
- Cerebrospinal Fluid Leakage, Subdural
- Interventions
- Device: Spinal SealantOther: Standard of Care
- Registration Number
- NCT00444067
- Lead Sponsor
- Integra LifeSciences Corporation
- Brief Summary
To evaluate a spinal sealant as an adjunct to sutured dural repair compared to standard of care techniques.
- Detailed Description
Neurosurgical procedures in the spine often involve incision of the dura mater to access the spinal cord. If the dural incision is not properly repaired and watertight closure is not achieved cerebrospinal fluid (CSF) can escape presenting a risk for significant morbidity. The most frequent complication of CSF leak is recurring headache complicated with symptoms of nausea and vomiting. Furthermore fluid collection under skin prevents proper wound healing and may lead to wound breakdown and infection of the incision or both. Persistent CSF leak has also been associated with the development of cerebellar hemorrhage and subdural hematoma. Primary repair and watertight closure are paramount to minimizing risk and sequelae associated with CSF leak.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 98
- Subjects scheduled for a spinal procedure that requires a dural incision
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Spinal Sealant System Spinal Sealant Spinal Sealant System Standard of Care Standard of Care Standard of care methods as an adjunct to sutured dural repair
- Primary Outcome Measures
Name Time Method Percent(%) Success in Obtaining a Watertight Closure Following Assigned Treatment (Spinal Sealant or Control) Intra-operative Percent(%) success in obtaining a watertight closure following assigned treatment (Spinal Sealant or Control) where success is defined as:
A watertight closure of the dural repair intraoperatively after study treatment, confirmed by Valsalva maneuver at 20-25 cm H2O for 5-10 seconds.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Confluent Surgical, Inc.
🇺🇸Bedford, Massachusetts, United States